Skip to main content
All lobbying filings

FEDERAL HEALTH POLICY STRATEGIES

Lobbying for KIDNEY CARE PARTNERS · Representation of dialysis providers.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $80,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 4
  • HR 2199
    Restore Protections for Dialysis Patients Act
  • S 1173
    Restore Protections for Dialysis Patients Act
  • S 2730
    Kidney Care Access Protection Act
  • HR 6214
    Kidney Care Access Protection Act
 Lobbying activity 2
Medicare/Medicaid

H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.

Health Issues

H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; S. 2730 and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; H.R. 6214 and issued related to clinical innovation, labor cost increases and access to kidney disease education and screening services.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem